Seeking Alpha

Shares of Inhibitex (INHX +2.3%) tack on a gain, helped along with a note from Noble Financial's...

Shares of Inhibitex (INHX +2.3%) tack on a gain, helped along with a note from Noble Financial's Nathan Cali to clients saying he believes the firm's INX-189 drug increases the chances of a "lucrative" partnership deal or merger in the future.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs